pancreatic-cancer

Documents about pancreatic-cancer

• GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors#889624ClinicalTrials.gov
• Using Electrical Bioimpedance Assessments to Estimate Perioperative Total Body Water and Postoperative Fluid Need#862856ClinicalTrials.gov
• Global, regional, and national analyses of the burden of pancreatic cancer attributable to high fasting plasma glucose from 1990 to 2021: A longitudinal observational study.#122998NCBI PubMed Central
• Bilioenteric Anastomosis by Magnetic Compressive Technique#894987ClinicalTrials.gov
• An Open-Label, Dose-Escalation Study of INCB054329 in Patients With Advanced Malignancies#807660ClinicalTrials.gov
• RNA-seq dataset: GB1275, a small-molecule agonist of cd11b, combined with drug-loaded oncolytic bacteria for pancreatic cancer therapy.#359847Figshare
• A Mixed-Methods Approach to Assessing Barriers and Facilitators to Cancer Genetics Care in Black and Latino/a Individuals Impacted by Pancreatic Cancer: The Racial/ethnic Equity in GENetic Education, Risk Assessment, and TEsting (REGENERATE) Study.#138532NCBI PubMed Central
• C11-Erlotinib PET/CT as a Tool for Identification and Characterization of Tumor With High Expression of Epidermal Growth Factor Receptor(EGFR).#860045ClinicalTrials.gov
• Dostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSI#127577ClinicalTrials.gov
• Emergence of Bacterial Resistance to Antibiotics in the Digestive Microbiota of Patients Treated With Anticancer Drugs#377263ClinicalTrials.gov
• First-in-human EphA2-targeting PET imaging with the bicyclic radiotracer [68Ga]Ga-BCY18469 in pancreatic cancer patients: biodistribution, dosimetry and initial findings#661856Deutsche Nationalbibliothek
• Family and Personal History of Malignancy in Intraductal Papillary Mucinous Neoplasm (IPMN)#871154ClinicalTrials.gov
• Effectiveness of the Transversus Abdominis Plane Block Associated With Opioid Spinal Anesthesia on Analgesia After Cephalic Duodenopancreatectomy#871466ClinicalTrials.gov
• A Study to Test Different Doses of BI 765049 in People With Advanced Cancer of the Colon, Rectum, Stomach, or Pancreas#883995ClinicalTrials.gov
• A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9#888748ClinicalTrials.gov
• Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors#874771ClinicalTrials.gov
• Comparative Analysis of Primary and Liver Fibroblasts Reveals MET as a Potent Target in Pancreatic Cancer Metastasis#661944Europe PMC
• A Dose Escalation and Cohort-Expansion Study of Oral eFT508 in Subjects With Advanced Solid Tumors#800997ClinicalTrials.gov
• Promitil Treatment of Patients With Solid Tumors Associated With Deleterious Mutations Who Have Progressed After Therapy#825279ClinicalTrials.gov
• Preoperative CA 19.9 Level Predicts Lymph Node Metastasis in Resectable Adenocarcinoma of the Head of the Pancreas.#897479ClinicalTrials.gov
• Step-by-Step Pancreaticoduodenectomy in Complete Situs Inversus: Technical Strategy to Preserve Oncologic Principles in a Rare Anatomical Setting#178173HAL (France)
• Temozolomide and Survivin Long Peptide Vaccine (SurVaxM) for the Treatment of Patients With Progressing Metastatic Neuroendocrine Carcinomas#195398ClinicalTrials.gov
• Key molecular mechanisms of mitochondrial metabolic pathways in specific cell subpopulations of pancreatic cancer based on scRNA-seq and bulk RNA-seq#335925PLOS
• Proteomic Analysis of HLA Complex in Solid Cancers: Breast, Ovary, Colon, Rectum, Stomach, and Pancreas#909240ClinicalTrials.gov
• SMMART Adaptive Clinical Treatment (ACT) Trial#805987ClinicalTrials.gov
• Efficacy and Safety of Endobiliary Radiofrequency Ablation by Using a Novel RF Catheter (ELRA®) on Maintaining the Patency of Endobiliary Metal Drainage in Patients With Malignant Biliary Strictures : A Double-arm Comparable Study#901274ClinicalTrials.gov
• A First-in-human Study of BGB-53038, a Pan-KRAS Inhibitor, Alone or in Combinations in Participants With Advanced or Metastatic Solid Tumors With KRAS Mutations or Amplification#805511ClinicalTrials.gov
• Development and validation of a deep learning radiomics model based on ultrasound and clinical features to predict prognosis in elderly patients with advanced pancreatic cancer after HIFU therapy.#3951NCBI PubMed Central
• Evaluation of hypofractionated adaptive radiotherapy using the MR Linac in localised pancreatic cancer: protocol summary of the Emerald-Pancreas phase 1/expansion study located at Oxford University Hospital, UK#240368Ora Oxford University Research
• Novel Arterial Reconstruction of the Left Gastric Artery Supplying the Replaced Left Hepatic Artery in Distal Pancreatectomy with Celiac Axis Resection#345339OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• Câncer de pâncreas no Sistema Único de Saúde: análise das internações e dos procedimentos cirúrgicos em Sergipe (2013–2025)#434669Repositório Institucional da Universidade Federal de Sergipe
• Dose Escalation/Expansion Study of Mavrostobart (PT199), an Anti-CD73 mAb, Administered Alone and in Combination With a PD-1 Inhibitor or Chemotherapy (the MORNINGSTAR Study)#268024ClinicalTrials.gov
• Epidemiological Assessment of the Risk for Pancreatic Cancer Associated With the Use of Semaglutide in Patients With Type 2 Diabetes - A Cohort Study Based on Nordic Registry Data#651192ClinicalTrials.gov
• Comparison Of Radiation Exposure To Patients During Endoscopic Retrograde Cholangiopancreatography (ERCP) Performed By Endoscopists Trained In Judicious Use Of Fluoroscopy With Those Without Formal Training#893683ClinicalTrials.gov
• Preventing Viral Pandemic Associated Risk of Cancer Death Using Less Invasive Diagnostic Tests- Liquid Biopsies#862597ClinicalTrials.gov
• A Study of JAB-3312 in Adult Patients With Advanced Solid Tumors in China#906979ClinicalTrials.gov
• Modified Wet Suction Versus Capillary Techniques for EUS Guided Fine Needle Aspiration and Biopsy of Solid Lesions#839231ClinicalTrials.gov
• Nutritional Preferences and Product Accessibility in Oral Nutritional Supplements in Participants With Breast, Colorectal, Upper Gastrointestinal, or Prostate Cancer#901414ClinicalTrials.gov
• Supplementary file 1_Targeting cancer matrix mechanics: fibronectin fiber relaxation correlates with ADAM8 expression in PDAC and is amenable to in vitro modulation.pdf#430025Figshare
• A Study of ASP1948, Targeting an Immune Modulatory Receptor as a Single Agent and in Combination With a PD-l Inhibitor (Nivolumab or Pembrolizumab) in Subjects With Advanced Solid Tumors#889138ClinicalTrials.gov
• A Study to Evaluate Safety, Pharmacokinetics, & Activity of RO7496353 in Combination With a Checkpoint Inhibitor With or Without Standard-of-care Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors; Urothelial Carcinoma Substudy in Association With RO7496353 Study GO44010#802106ClinicalTrials.gov
• Doxorubicin Beads in Treating Patients With Unresectable Liver Metastases From Neuroendocrine Tumors#845996ClinicalTrials.gov
• Niraparib and TSR-042 for the Treatment of BRCA-Mutated Unresectable or Metastatic Breast, Pancreas, Ovary, Fallopian Tube, or Primary Peritoneal Cancer#833591ClinicalTrials.gov
• Cisplatin and Etoposide Versus Temozolomide and Capecitabine in Patients With Advanced Poorly Differentiated (G3) Non-Small Cell Gastrointestinal Neuroendocrine Carcinomas#872596ClinicalTrials.gov
• Study of [68Ga]-FF58 in Patients With Selected Solid Tumors Expected to Overexpress αvβ3 and αvβ5 Integrins.#880737ClinicalTrials.gov
• A Dose-Finding Study of Birabresib (MK-8628), a Small Molecule Inhibitor of the Bromodomain and Extra-Terminal (BET) Proteins, in Adults With Selected Advanced Solid Tumors (MK-8628-003)#802132ClinicalTrials.gov
• 131Iodine-Tenatumomab Treatment in Tenascin-C Positive Cancer Patients#859994ClinicalTrials.gov
• EUS-guided Choledochoduodenostomy vs ERCP as First Line in Malignant Distal Obstruction in Resectable Disease (CARPEDIEM-1 Trial)#884850ClinicalTrials.gov
• FAPi Radioligand OpeN-Label, Phase 1 Study to Evaluate Safety, Tolerability and DosImetry of [Lu-177]-PNT6555; A Dose Escalation Study for TReatment of Patients With Select Solid Tumors (FRONTIER)#882957ClinicalTrials.gov
• ATM deficiency induces TGFβ-mediated stromal programming in pancreatic cancer / Elodie Roger, Hannah M. Mummey, Eleni Zimmer, Dharini Srinivasan, Anna Härle, Loïc Moubri, Alica K. Michels, Rima Singh, Menar Ekizce, Michael K. Melzer, Yun Lee, Austin Silva, Luisa Härle, Thomas Engleitner, Frank Arnold, Mareen Morawe, Benjamin Karem Naggay, Juliane Schneider, Leonard Gilberg, Julia P. Mosler, Christina Ludwig, Chen Meng, Maximilian Hirschenberger, Victoria Hunszinger, Klaus Kluck, Martina Kirchner, Anna-Lena Volckmar, Mareike Wirth, Mohamed S.S. Alhamdani, Jörg D. Hoheisel, J.-Matthias Löhr, Thomas Seufferlein, Alireza Abaei, Ralf Kemkemer, Roland Rad, Jan Budczies, Medhanie A. Mulaw, Patrick C. Hermann, Mark M. Haenle, Konstantin M.J. Sparrer, Christopher J. Halbrook, Kyle J. Gaulton, Konrad Steinestel, Albrecht Stenzinger, Nelson Dusetti, Lukas Perkhofer, Johann Gout, Alexander Kleger#783994Deutsche Nationalbibliothek